IBIO - Coronavirus Madness: Penny Stocks That Scored Big For Investors

February, 27 2020 07:38 PM iBio Inc.

Short List of Penny Stocks That Brokeout Big Coronavirus Concerns

Say what you will about penny stocks but during times like these, people wish they followed micro-caps. Over the better part of the last few months, PennyStocks.com has covered countless stocks. But for some penny stocks, we aren’t just mentioning them once and then forgetting about them. These are the ones that consistently show momentum and progress. For that reason, we make sure to cover them a bit more closely.

Whymention this right now? Well, consider this getting the house in order andgoing over a few things that have our readers seeing companies before and whilebreakouts take place. In some cases, the moves have been unlike anything I’msure many of you have ever seen. We aren’t talking a few percentage points, buthundreds and even thousands of real moves from penny stocks that trade millionsof dollars per day.

Arewe stock pickers? No, nor are we advisors or financial representatives of anykind. We simply make sure to focus on interesting penny stocks and hope thatyou get a little value out of it. If anything, we hope that it gives you a startingpoint to do your own research. Now, let’s get to the details. The name of thegame has been coronavirus stocks.

CoronavirusPenny Stocks

While that’s the flavor of the month right now, many of the companies you’ll see have other pipeline treatments that could help these companies build far beyond however long this coronavirus scare lasts. We’ve lived through SARS, MERS, Ebola, Zika, etc. And while these viruses come and go from the news cycle, so too does the FOMO behind the mad rush to buy the stocks.

So, keep this in mind when looking at certain penny stocks because if/when there is a vaccine sooner or later, you’ll want to refocus your attention on something other than a coronavirus treatment in my opinion. This being said, let’s get a rundown of some of the coronavirus penny stocks we’ve mentioned, when they were discussed more consistently, and where they’re at today.

iBio, Inc. (IBIO) – 400%

This was one of the biotech penny stocks we mentioned here and there but started to mention it more frequently starting in December. It was when iBio, Inc. (IBIO – Free Report) announced its membership in a “public-private Manufacturing USA initiative”. At the time (December 3, 2019) IBIO stock was trading around $0.20.

Asof February 27, the stock has reached $1 just after the market closed. Not abad 400% move for a small-cap biotech penny stock? Recently, the companyreported that along with CC-Pharminginitiated a joint development of a coronavirus vaccine. But aside from that,the company has other projects at work.

Allied Healthcare Products (AHPI) – 618%

While Allied Healthcare Products (AHPI – Free Report) had a great run last month, we started to follow it more closely this month. February 11 is when we first started following the stock at around $2.50. If you’ve watched since then, you already know how big of a monster it has become. The top blew off the penny stock on February 27 when coronavirus fears were at a fever pitch. Since the 11^th and over the weeks to follow we watched as AHPI stock went on this epic 618% rally.

In the case of Allied Healthcare, it was very much a sympathy play in my opinion. It manufactures respiratory products. Based on coronavirus impacting the respiratory system it wasn’t the farthest-reaching story to follow.

However,the company hasn’t put out any news to justify such a move. But, FOMO helpedspark a massive run. Meanwhile, you had a low float environment to consider,which is likely why it went parabolic on Thursday. Needless to say, our readerswere able to see this penny stock well in advance of even its move up to $4 letalone $17.95.

Vaxart Inc. (VXRT) – 243%

Anotherone of the coronavirus penny stocks we’ve covered since January is VaxartInc. (VXRT – Free Report).At the time it traded around $0.99 and has since jumped to highs of $3.40. Itwas definitely a big move. But it wasn’t based on speculation alone. Thecompany actually has active trials going on, which were initially were for H1influenza.

Theobvious synergies between the flu and coronavirus are evident and a potentialcatalyst behind the original spark. However, as we’ve discussed over the lastfew weeks, things have evolved a bit. Vaxart took that technology and appliedit to a potential vaccine for coronavirus.

Evenif coronavirus goes away tomorrow, Vaxart still has a viable product candidate ina flu vaccine. While there hasn’t been news since the end of January, it doesn’tseem odd that shares have managed to catch momentum as they have. That’s simplydue to the fact that there’s actually material, relevant, and recentinformation out there for the public to consume.

Ritter Pharmaceuticals Inc. (RTTR) – 115%

Next,Ritter Pharmaceuticals (RTTR– Free Report) started the year off around $0.17 when wee began covering itagain. One of the interesting things here is that the company was seeing volumeamid corporate uncertainty. In fact, Ritter actually brought on a firm as astrategic advisor to explore different options. Needless to say, they foundsomething in a company called Qualigen.

The two signed definitive agreements to merge Ritter with Qualigen and Ritter will change its name once complete. Since Qualigen is a company focused on treating infectious diseases, it makes sense to see the early momentum from January to translate the way it has. Since January, RTTR stock has climbed as high as $0.3659 on Feb. 27. It should also be noted that there have been two big pushes since the beginning of the year and our readers got to see them both, pre- and post-related to coronavirus FOMO.

Alpha Pro Tech Ltd. (APT) – 535%

This is one of the coronavirus penny stocks we didn’t cover as much. But that’s simply due to the fact that Alpha Pro Tech (APT – Free Report) took off running almost immediately following our first article. This is another case of sympathy and FOMO. You know what the company does? It sells face masks for, among other things, medical needs; that’s it.

This is how APT stock is related to the coronavirus. But obviously it struck a chord with some people after our January 24^th update. What’s more is that according to a PR this week, APT has now booked approximately $14.1 million in orders for the company’s N-95 face mask since January 27, 2020. Since the 24th APT stock has rallied from around $5.30 to highs of $33.61 during after-hours trading on February 27.

AIM ImmunoTech Inc. (AIM) – 145%

This is one of the penny stocks to watch for a while now. However, since the surge of interest in coronavirus has picked up, AIM ImmunoTech Inc. (AIM – Free Report) has turned even more heads. At the time we started following the stock, shares traded around $0.80 (Jan. 21). At the time it was just as AIM reported a slew of insider buying. It also had just updated on its immune-oncology clinical trials. On a broad level, the company works to develop treatments for viral and immune-based disorders.

Obviously, the new virus is something that would go into that category. But then in February, we saw how the company really targeted the virus directly. Aside from discussing it on Cheddar and Fox Business, it filed 3 provisional patent applications for Ampligen for use against the virus. Furthermore, AIM reported that it joined with ChinaGoAbroad to allow entry of its experimental drug into the People’s Republic of China. The goal is to use it as an early onset therapeutic against COVID-19.

NanoViricides (NNVC) – 442%

NanoViricides (NNVC – Free Report) is another penny stock similar to APT where we didn’t have too long of a chance to actually cover the company due to the price leaving penny stock territory. Initially, when I saw our article published on January 21^st, it was a bit disheartening because it was after the market close. On that day, shares of NNVC jumped from $3.54 to $13.45 so you can understand the frustration there. However, we did mention it in passing in October but I’m not sure if that was an actually viable topic considering we didn’t have consistency at the time.

Needlessto say, this time around, we were on the ball. On January 22 shares opened at$3.97 and that “frustration” immediately went away. Since then, the stock hasnot only gone on an initial run to highs of $19.20 but after coming back downto earth, it’s gone on another jaunt to highs of $12.90 on February 27.

How’sNanoViricides related to coronavirus? In the company’s pipeline, NanoViricideshas an experimental flue drug called FluCide™. It’s used for hospitalizedpatients. Specifically, it’s been designed to treat influenza viruses“including pandemic viruses, highly pathogenic avian influenza viruses capableof causing severe human epidemics.

Company Name:	iBio Inc.
Stock Symbol:	IBIO
Market:	NYSE
Website:	ibioinc.com

Twitter

IBIO - Coronavirus Madness: Penny Stocks That Scored Big For Investors

Short List of Penny Stocks That Brokeout Big Coronavirus Concerns

CoronavirusPenny Stocks

iBio, Inc. (IBIO) – 400%

More Articles On IBIO

Allied Healthcare Products (AHPI) – 618%

More Articles on AHPI

Vaxart Inc. (VXRT) – 243%

More Articles On VXRT

Ritter Pharmaceuticals Inc. (RTTR) – 115%

More Articles On RTTR

Alpha Pro Tech Ltd. (APT) – 535%

More Articles On APT

AIM ImmunoTech Inc. (AIM) – 145%

More Articles On AIM

NanoViricides (NNVC) – 442%

More Articles On NNVC